Androclus Therapeutics
Latest round
- Series A
Last raised
- May 2005
Total raised
- Undisclosed
Investors
- 2
About Androclus Therapeutics
Androclus Therapeutics Inc. is the biotech company. It focused on autoimmune and inflammatory diseases.
Who invested in Androclus Therapeutics
2 investors across 1 round
See all investors in Androclus Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 16, 2005
Amount
Undisclosed
Investors
Questions about Androclus Therapeutics
Who invested in Androclus Therapeutics?
Androclus Therapeutics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Androclus Therapeutics raised?
Androclus Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Androclus Therapeutics last raise money?
Androclus Therapeutics's most recent round on record is a Series A, in May 2005.
What does Androclus Therapeutics do?
Androclus Therapeutics is a biotechnology company.
Where is Androclus Therapeutics headquartered?
Androclus Therapeutics is headquartered in San Diego, US.
Which VCs invest in companies like Androclus Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Androclus Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Androclus Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.